研報掘金丨華鑫證券:維持東鵬飲料“買入”評級,盈利能力平穩提升
華鑫證券研報指出,23年東鵬飲料(605499.SH)收入利潤雙高增,繼續堅實龍頭地位。根據尼爾森,東鵬特飲在我國能量飲料市場銷售量佔比由2022年末的36.07%提升至43.02%,排名保持第一。盈利能力平穩提升,市場投入持續加大。2023年經營淨現金流32.81億元(同增61.95%),銷售回款139.00億元(同增37.07%)。看好公司在能量飲料主賽道上繼續提升市場份額,同時電解質水等新品實現較快增長,成為第二增長曲線。當前股價對應PE分別為29/23/19倍,維持“買入”投資評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.